Catherine A. Sohn - Sep 28, 2023 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/ Richard Eisenstadt, as Attorney-in-Fact
Stock symbol
ALT
Transactions as of
Sep 28, 2023
Transactions value $
$0
Form type
4
Date filed
9/29/2023, 05:01 PM
Previous filing
Aug 15, 2023
Next filing
Sep 30, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALT Stock Options (option to buy) Award $0 +26.1K $0.00 26.1K Sep 28, 2023 Common Stock, par value $0.0001 26.1K $2.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 28, 2023, subject to the reporting person's continued service through the applicable vesting date.